Biology Reference
In-Depth Information
Genc K, Sagiroglu E, Cerami A, Brines M
(2002) Erythropoietin prevents motor neu-
ron apoptosis and neurologic disability in
experimental spinal cord ischemic injury. Proc
Natl Acad Sci U S A 99:2258-2263
120. Gorio A, Gokmen N, Erbayraktar S, Yilmaz
O, Madaschi L, Cichetti C, Di Giulio AM,
Vardar E, Cerami A, Brines M (2002)
Recombinant human erythropoietin counter-
acts secondary injury and markedly enhances
neurological recovery from experimental spi-
nal cord trauma. Proc Natl Acad Sci U S A
99:9450-9455
121. Kilic E, Kilic U, Soliz J, Bassetti CL, Gassmann
M, Hermann DM (2005) Brain-derived
erythropoietin protects from focal cerebral
ischemia by dual activation of ERK-1/-2 and
Akt pathways. FASEB J 19:2026-2028
122. Sola A, Wen TC, Hamrick SE, Ferriero DM
(2005) Potential for protection and repair fol-
lowing injury to the developing brain: a role
for
of adult CNS neurons via Jak2/Stat3 and
PI3K/AKT pathway activation. Mol Cell
Neurosci 29:569-579
130. Ehrenreich H, Hasselblatt M, Dembowski C,
Cepek L, Lewczuk P, Stiefel M, Rustenbeck
HH, Breiter N, Jacob S, Knerlich F, Bohn M,
Poser W, Ruther E, Kochen M, Gefeller O,
Gleiter C, Wessel TC, De Ryck M, Itri L,
Prange H, Cerami A, Brines M, Siren AL
(2002) Erythropoietin therapy for acute
stroke is both safe and beneficial. Mol Med
8:495-505
131. Ehrenreich H, Weissenborn K, Prange H,
Schneider D, Weimar C, Wartenberg K,
Schellinger PD, Bohn M, Becker H, Wegrzyn
M, Jahnig P, Herrmann M, Knauth M, Bahr
M, Heide W, Wagner A, Schwab S, Reichmann
H, Schwendemann G, Dengler R, Kastrup A,
Bartels C (2009) Recombinant human eryth-
ropoietin in the treatment of acute ischemic
stroke. Stroke 40:e647-e656
132. Wustenberg T, Begemann M, Bartels C,
Gefeller O, Stawicki S, Hinze-Selch D, Mohr
A, Falkai P, Aldenhoff JB, Knauth M, Nave
KA, Ehrenreich H (2011) Recombinant
human erythropoietin delays loss of gray mat-
ter in chronic schizophrenia. Mol Psychiatry
16(26-36):21
133. Miskowiak K, O'Sullivan U, Harmer CJ
(2007) Erythropoietin reduces neural and
cognitive processing of fear in human models
of antidepressant drug action. Biol Psychiatry
62:1244-1250
134. Ehrenreich H, Fischer B, Norra C,
Schellenberger F, Stender N, Stiefel M, Siren
AL, Paulus W, Nave KA, Gold R, Bartels C
(2007) Exploring recombinant human eryth-
ropoietin in chronic progressive multiple scle-
rosis. Brain 130:2577-2588
135. Tseng MY, Hutchinson PJ, Richards HK,
Czosnyka M, Pickard JD, Erber WN, Brown
S, Kirkpatrick PJ (2009) Acute systemic eryth-
ropoietin therapy to reduce delayed ischemic
deficits following aneurysmal subarachnoid
hemorrhage: a Phase II randomized, double-
blind, placebo-controlled trial. Clinical article.
J Neurosurg 111:171-180
136. Nirula R, Diaz-Arrastia R, Brasel K, Weigelt
JA, Waxman K (2010) Safety and efficacy of
erythropoietin in traumatic brain injury
patients: a pilot randomized trial. Crit Care
Res Pract pii:209848
137. Asaumi Y, Kagaya Y, Takeda M, Yamaguchi N,
Tada H, Ito K, Ohta J, Shiroto T, Shirato K,
Minegishi N, Shimokawa H (2007) Protective
role of endogenous erythropoietin system in
nonhematopoietic cells against pressure over-
load-induced left ventricular dysfunction in
mice. Circulation 115:2022-2032
erythropoietin?
Pediatr
Res
57:
110R-117R
123. Viviani B, Bartesaghi S, Corsini E, Villa P,
Ghezzi P, Garau A, Galli CL, Marinovich
M (2005) Erythropoietin protects primary
hippocampal neurons increasing the expres-
sion of brain-derived neurotrophic factor.
J Neurochem 93:412-421
124. Weishaupt JH, Rohde G, Polking E, Siren
AL, Ehrenreich H, Bahr M (2004) Effect of
erythropoietin axotomy-induced apoptosis in
rat retinal ganglion cells. Invest Ophthalmol
Vis Sci 45:1514-1522
125. Shen J, Wu Y, Xu JY, Zhang J, Sinclair SH,
Yanoff M, Xu G, Li W, Xu GT (2010) ERK-
and Akt-dependent neuroprotection by eryth-
ropoietin (EPO) against glyoxal-AGEs via
modulation of Bcl-xL, Bax, and BAD. Invest
Ophthalmol Vis Sci 51:35-46
126. Grimm C, Wenzel A, Stanescu D, Samardzija
M, Hotop S, Groszer M, Naash M, Gassmann
M, Reme C (2004) Constitutive overexpression
of human erythropoietin protects the mouse
retina against induced but not inherited retinal
degeneration. J Neurosci 24:5651-5658
127. Konishi Y, Chui DH, Hirose H, Kunishita T,
Tabira T (1993) Trophic effect of erythropoi-
etin and other hematopoietic factors on cen-
tral cholinergic neurons in vitro and in vivo.
Brain Res 609:29-35
128. Bocker-Meffert S, Rosenstiel P, Rohl C,
Warneke N, Held-Feindt J, Sievers J, Lucius
R (2002) Erythropoietin and VEGF promote
neural outgrowth from retinal explants in
postnatal rats. Invest Ophthalmol Vis Sci
43:2021-2026
129. Kretz A, Happold CJ, Marticke JK, Isenmann
S (2005) Erythropoietin promotes regeneration
Search WWH ::
Custom Search